SNCE — Science 37 Holdings Share News
0.000.00%
Last trade - 00:00- $34.54m
- -$21.87m
- $70.15m
Brief: Science 37® Extends Leadership In Decentralized Clinical Trial Market With NextGen SaaS Release To Fully Orchestrate Decentralized Study Conduct
Science 37 Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Science 37 Reports First Quarter 2022 Financial Results
Science 37 Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Adobe, Aligos Therapeutics
U.S. RESEARCH ROUNDUP- Adobe, Aligos Therapeutics
Science 37 Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Science 37 Reports Fourth Quarter And Full Year 2021 Financial Results
Science 37 Holdings Inc expected to post a loss of 21cents a share - Earnings Preview
Brief: Science 37® And Physiq Collaborate To Enhance Clinical Trial Data Collected From Connected Devices
Brief: Science 37 Furthers Global Expansion With Capabilities In China And Russia To Advance Decentralized Clinical Trials And Accelerate Development
Science 37 Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Science 37 Reports Quarterly Financial Results
Science 37 Holdings Inc expected to post a loss of $5.32 a share - Earnings Preview
Brief: Science 37 And Cmic Announce Partnership To Advance Decentralized Clinical Trials In Japan/Apac And Speed Drug Development
Brief: Science 37 And 3H MEDI Solution Collaborate To Enable Decentralized Clinical Trials In Japan And Accelerate Patient Enrollment
Cowen says Science 37 well positioned for growth, starts coverage
NASDAQ RESUMED AT 02:17 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:13 PM